Artikel ; Online: Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects.
Drug design, development and therapy
2024 Band 18, Seite(n) 567–581
Abstract: Purpose: This study explored the pharmacokinetics (PK), pharmacodynamics (PD), and safety of evocalcet (KHK7580), a new calcimimetic agent, in healthy Chinese subjects following single and multiple doses.: Methods: This was a single-center, open- ... ...
Abstract | Purpose: This study explored the pharmacokinetics (PK), pharmacodynamics (PD), and safety of evocalcet (KHK7580), a new calcimimetic agent, in healthy Chinese subjects following single and multiple doses. Methods: This was a single-center, open-label phase I trial conducted in China. The study started from the single-dose cohorts (1, 3, 6, 12 mg evocalcet, step-by-step administration) and proceeded to the multiple-dose cohort (6 mg evocalcet once daily for eight days). Blood and urine samples were collected at the designated time points for pharmacokinetic and pharmacodynamic analysis. Safety was evaluated by treatment-emergent adverse events (TEAEs), clinical laboratory tests, vital signs, electrocardiograms (ECGs), and ophthalmological examination. Results: Among 42 enrolled subjects, eight in each single-dose cohort and 10 in multiple-dose cohort, 40 subjects completed the study. In single-dose cohorts, t Conclusion: In healthy Chinese subjects, evocalcet demonstrated dose-dependent PK and PD properties and was well-tolerated. |
---|---|
Mesh-Begriff(e) | Humans ; Naphthalenes ; Pyrrolidines ; Asian People ; Calcimimetic Agents ; China |
Chemische Substanzen | evocalcet (E58MLH082P) ; Naphthalenes ; Pyrrolidines ; Calcimimetic Agents |
Sprache | Englisch |
Erscheinungsdatum | 2024-02-26 |
Erscheinungsland | New Zealand |
Dokumenttyp | Clinical Trial, Phase I ; Case Reports ; Clinical Trial |
ZDB-ID | 2451346-5 |
ISSN | 1177-8881 ; 1177-8881 |
ISSN (online) | 1177-8881 |
ISSN | 1177-8881 |
DOI | 10.2147/DDDT.S437903 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.